IRCT20181203041835N1 IRCT 2019-02-19 Rafsanjan University of Medical Sciences The effect of powdered green tea in patients with coronary artery disease The effect of powdered green tea enriched with epigallocatchin gallate (EGCG) on some clinical, electrophysiological, biochemical, inflammatory and antioxidant parameters in patients with coronary artery disease, a randomized, triple blind clinical trial 2018-12-22 anticipated 80 Complete https://irct.ir/trial/35830 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Stratified randomization by minimization method: in this method, initially, the patients will categorize based on key variables, such as age and sex. Afterwards, from the patients who will meet the inclusion criteria, the first participant will place in the intervention or control group by coin flip, and other participants will allocate to the study group with lower total of variables, Blinding description: Drug and placebo were delivered as drugs 1 and 2, and the researcher will blind to placebo or drug of capsules. The patient also will not know that he is in the drug group or placebo. The analyst will not know the groups and will perform the analysis as group 1 and 2. 2-3 Coronary Artery Disease (CAD). Intervention 1: Control group: The group that consumes a 500 mg capsule containing cellulose .Daily two capsules for 3 months.This capsule is prepared by the Essential Oil Pharmaceutical Company. Intervention 2: Intervention group: The group that consumes a 500 mg capsule containing EGCG-rich green tea powder.Daily two capsules for 3 months.This capsule is prepared by the Essential Oil Pharmaceutical Company. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information